Cells from the centre of tumours are most likely to spread around the body
Research published in the journal Nature Ecology and Evolution led [...]
ESMO 2019: First in human study of HIF-2α inhibitor in patients with advanced kidney cancer
Results from the first in human study of the HIF-2α [...]
Neoadjuvant axitinib to allow partial nephrectomy of cT2a renal tumours
A phase 2 study published in the British Journal of [...]
ASCO GU 2019: Early tumour shrinkage and improved survival with cabozantinib
The results from the following study were presented at the [...]
Treatment-related hyperprogression
The following article from Cancer Therapy Advisor presents the arguments for [...]
Neoadjuvant axitinib shrinks kidney tumours to allow for partial nephrectomy
A recent phase II study of 18 patients with clear-cell renal [...]
Depleted levels of metabolic enzymes promote kidney cancer tumour growth
Researchers at the University of Pennsylvania in Philadelphia, USA, have [...]
